Cure Glaucoma Foundation is located in Dallas, TX. The organization was established in 2016. According to its NTEE Classification (Q33) the organization is classified as: International Relief, under the broad grouping of International, Foreign Affairs & National Security and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Cure Glaucoma Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Cure Glaucoma Foundation generated $484.4k in total revenue. This organization has experienced exceptional growth, as over the past 8 years, it has increased revenue by an average of 17.8% each year . All expenses for the organization totaled $543.3k during the year ending 12/2023. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
THE MISSION OF CURE GLAUCOMA IS TO IMPROVE GLAUCOMA BY FUNDING TRANSFORMATIONAL RESEARCH, DISSEMINATING KNOWLEDGE AND EXPANDING TREATMENT AVAILABILITY THROUGH GLOBAL OUTREACH EFFORTS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
CGFS MISSION IS TO IMPROVE QUALITY CARE FOR ALL PEOPLE, FUND TRANSFORMATIONAL RESEARCH AND DISSEMINATE KNOWLEDGE THROUGH GLOBAL OUTREACH EFFORTS.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Mike Kettles Exec Dir/treas | OfficerTrustee | 40 | $78,895 |
W Stephen Love President | OfficerTrustee | 1 | $0 |
Helen L Kornmann MD PHD Secretary | OfficerTrustee | 1 | $0 |
Davinder S Grover MD MPH Director | Trustee | 1 | $0 |
Joseph K Haggerty Director | Trustee | 1 | $0 |
Bradley F Jost MD Director | Trustee | 1 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $483,684 |
Noncash contributions included in lines 1a–1f | $329,273 |
Total Revenue from Contributions, Gifts, Grants & Similar | $483,684 |
Total Program Service Revenue | $0 |
Investment income | $691 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $484,375 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $37,050 |
Grants and other assistance to domestic individuals. | $1,000 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $78,895 |
Compensation of current officers, directors, key employees. | $7,846 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $0 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $0 |
Payroll taxes | $0 |
Fees for services: Management | $0 |
Fees for services: Legal | $0 |
Fees for services: Accounting | $2,700 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $22,601 |
Advertising and promotion | $24,460 |
Office expenses | $0 |
Information technology | $6,410 |
Royalties | $0 |
Occupancy | $0 |
Travel | $34,361 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $19 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $747 |
Insurance | $0 |
All other expenses | $1,071 |
Total functional expenses | $543,318 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $79,236 |
Savings and temporary cash investments | $48,381 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $940 |
Net Land, buildings, and equipment | $3,503 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $132,060 |
Accounts payable and accrued expenses | $61 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $1 |
Total liabilities | $62 |
Net assets without donor restrictions | $131,998 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $132,060 |
Over the last fiscal year, Cure Glaucoma Foundation has awarded $32,000 in support to 2 organizations.
Grant Recipient | Amount |
---|---|
CATALYST FOR A CURE INITIATIV PURPOSE: RESEARCH | $25,000 |
CENTER FOR VISION HEALTH GLAU PURPOSE: RESEARCH | $7,000 |